RA
HALO icon

Royce & Associates’s Halozyme HALO Stock Holding History

Royce & Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67,000
Closed -$4.51M – 786
2025
Q4 		$4.51M Sell
67,000
-7,028
-9% -$473K 0.05% 480
2025
Q3 		$5.43M Sell
74,028
-13,001
-15% -$864K 0.05% 454
2025
Q2 		$4.53M Sell
87,029
-119,612
-58% -$6.81M 0.05% 480
2025
Q1 		$13.2M Buy
206,641
+9,642
+5% +$560K 0.14% 215
2024
Q4 		$9.42M Buy
196,999
+72,988
+59% +$3.74M 0.09% 337
2024
Q3 		$7.1M Sell
124,011
-52,716
-30% -$3.02M 0.06% 406
2024
Q2 		$9.25M Sell
176,727
-14,828
-8% -$650K 0.09% 330
2024
Q1 		$7.79M Buy
191,555
+52,245
+38% +$1.96M 0.07% 396
2023
Q4 		$5.15M Buy
+139,310
New +$5.25M 0.05% 490
2023
Q2 		– Sell
-45,000
Closed -$1.72M – 931
2023
Q1 		$1.72M Sell
45,000
-51,000
-53% -$2.39M 0.02% 686
2022
Q4 		$5.46M Hold
96,000
– – 0.06% 443
2022
Q3 		$3.8M Hold
96,000
– – 0.04% 506
2022
Q2 		$4.22M Buy
96,000
+64,000
+200% +$2.77M 0.04% 526
2022
Q1 		$1.28M Buy
+32,000
New +$1.14M 0.01% 780
2014
Q3 		– Sell
-1,200
Closed -$12K – 1415
2014
Q2 		$12K Sell
1,200
-64,875
-98% -$550K ﹤0.01% 1417
2014
Q1 		$839K Sell
66,075
-46,622
-41% -$692K ﹤0.01% 1170
2013
Q4 		$1.69M Sell
112,697
-35,000
-24% -$450K ﹤0.01% 1097
2013
Q3 		$1.63M Buy
147,697
+64,075
+77% +$534K ﹤0.01% 1106
2013
Q2 		$664K Buy
+83,622
New +$533K ﹤0.01% 1203

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates's HALO Position: Q1 2026 in Review

Royce & Associates sold out of Halozyme (HALO) in Q1 2026, closing a stake of 67,000 shares — an estimated $4.51M sold.

Royce & Associates first reported a position in HALO in Q2 2013 and held it in 19 quarters. The position peaked at $13.2M in Q1 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Royce & Associates reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Royce & Associates sold 67,000 Halozyme shares in Q1 2026, an estimated $4.51M.
  • Royce & Associates first reported a position in Halozyme in Q2 2013 and held it in 19 quarters.
  • Royce & Associates's Halozyme position peaked at $13.2M in Q1 2025.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.